Here is the latest stock price and chart of Dishman Pharma. For more details, see the Dishman Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Mega Webinar on Jan 29th: Will 2021 be a boom or bust?
Live BSE Quotes | May 29, 2017 (Close) | ||
---|---|---|---|
Price (Rs)301.05 | Open (Rs) 293.00 | High (Rs) 304.30 | Low (Rs) 278.10 |
% Change2.87 | Volume 460,499 | Value (Rs) 135,767,416 | 52-Week H/L 346.25 / 127.60 |
Live NSE Quotes | Jan 22, 2021 3:28:43 PM | ||
---|---|---|---|
Price (Rs)163.40 | Open (Rs) 163.25 | High (Rs) 165.95 | Low (Rs) 161.00 |
% Change0.12 | Volume 18,206 | Value (Rs) 2,959,567 | 52-Week H/L 347.00 / 127.95 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.87% | 1 Month -2.45% | 3 Months 30.49% | 1 Year 96.38% | 5 Years (CAGR)* 62.16% | 10 Years (CAGR)* 9.41% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 12.00 | P/E Ratio (x) 25.09 | Market Cap (Rs m) 48,587.66 | P/BV (x) 3.35 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DISHMAN PHARMA last traded price was up 0.1% to Rs 163.4 on the NSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark NIFTY 50 was at 14,371.9 (down 1.5%).
Over the last 30 days, the DISHMAN PHARMA share price is down 47.2%.
What else is happening in the markets today? Dig in...
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
Sorry! There are no related views on news for this company/sector.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More